SCHEMBL22010955

SCHEMBL22010955

CCCCCc1ccc(-c2cc3oc4cc(OCC)c(F)c(F)c4c3c(F)c2F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 9/20 0.40
ABCB1 P08183 1/20 0.39
MAPT P10636 4/20 0.38
RAB9A P51151 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RARA P10276 2/20 0.38
RARG P13631 1/20 0.38
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 2/20 0.35
USP2 O75604 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
TSHR P16473 1/20 0.35
MTOR P42345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010835 0.99 RARB (0.40) RARBABCB1MAPTRAB9AL3MBTL1
SCHEMBL22010998 0.92 RARB (0.44) RARBABCB1MAPTRAB9AL3MBTL1
SCHEMBL22010820 0.92 RARB (0.40) RARBABCB1S1PR1
SCHEMBL22010988 0.87 MPL (0.37) RARBABCB1MAPTRAB9AL3MBTL1
SCHEMBL22011803 0.86 CALM1 (0.35) MAPTRAB9AL3MBTL1FFAR4GPR55
SCHEMBL22011189 0.86 RARB (0.37) RARBMAPTRAB9AL3MBTL1RARA
SCHEMBL22011104 0.85 NAAA (0.33) RARBMAPTRAB9AL3MBTL1RARA
SCHEMBL22011081 0.84 MAOB (0.36) ABCB1ALDH1A1MEN1KMT2AHPGD
SCHEMBL22011813 0.84 S1PR1 (0.35) MAPTRAB9AL3MBTL1S1PR1
SCHEMBL22011103 0.83 RARB (0.42) RARBABCB1MAPTRAB9ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 RARB 2226/4885ABCB1 1178/4885MAPT 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.